Learn More About Power

Why We Started Power

My name is Bask, and I helped to start the company here. We started Power when my Dad was diagnosed with multiple myeloma, and I needed a better way to understand how he could access the most promising immunotherapy for his illness.

Bask
Bask GillCEO at Power
Learn More About Trials
How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
1045 Sansome St, Suite 321, San Francisco, CA
hello@withpower.com(415) 900-4227
About UsBrowse Clinical TrialsTreatment Support DossierUpdate A Trial Listing
We're hiring!
1
Conditions
Tinnitus
Retinitis Pigmentosa
Spinal Cord Injury
Essential Tremor
Obesity
Vitiligo
Lyme Disease
Lung Cancer
Breast Cancer
Pancreatic Cancer
Locations
Florida
New Jersey
North Carolina
Texas
Ohio
California
Pennsylvania
Kentucky
New York
Indiana
Psychology Related
Depression
Schizophrenia
Anxiety
PTSD
ADHD
Autism
Bipolar Disorder
Addiction
OCD
Eating Disorder
Treatments
Psilocybin
IVF
Dental Implant
Weight Loss
Smoking
Platelet-Rich Plasma
Testosterone
Saxenda
Melatonin
Entresto
Cities
Saint Louis
Columbus
Portland
Ann Arbor
Aurora
Salt Lake City
Rochester
Birmingham
Detroit
New Haven
Terms of ServicePrivacy PolicySecurity

Popular Searches

By Condition

Depression Clinical Trials in California

Anxiety Clinical Trials in California

Schizophrenia Clinical Trials in California

ADHD Clinical Trials in California

Bipolar Disorder Clinical Trials in California

Multiple Sclerosis Clinical Trials in California

By Location

Clinical Trials near Los Angeles, CA

Clinical Trials near San Francisco, CA

Clinical Trials near San Diego, CA

Clinical Trials near Sacramento, CA

Clinical Trials near La Jolla, CA

Clinical Trials near Orange, CA

Other People Viewed

Volrustomig for Advanced Throat Cancer

Gene Therapy for Frontotemporal Dementia

PT886 for Stomach Cancer

AZD0901 for Stomach Cancer

mRNA-3745 for Glycogen Storage Disease

Narrative Discourse Treatment for Traumatic Brain Injury

Auditory Brainstem Implant for Bilateral Hearing Loss

NIRAF Detection with PTeye for Hyperparathyroidism

Digital Mental Health Intervention for Self-Harm

Eplontersen for Transthyretin Amyloid Cardiomyopathy

Multiple Therapies for Stage III Non-Small Cell Lung Cancer

Online Physical Activity Intervention for Multiple Sclerosis

Condition
Suggestions
  • Depression
  • Schizophrenia
  • Bipolar Disorder
  • Anxiety Disorder
  • Dysthymia
Location
Suggestions
    Filter Results
    Conditions
    Suggestions
    • Depression
    • Schizophrenia
    • Bipolar Disorder
    • Anxiety Disorder
    • Dysthymia
    Locations
    Suggestions
      Treatment Type
      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Trial Phase

      Trial Status

      Paid Participation

      Clear All

      Home
      Long Beach, CA
      Show Map
      Map View
      Long Beach, CA
      Filters

      0

      Treatment Type
      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Paid Participation

      Trial Status

      Trial Phase

      Clear All
      Why We Started Power

      My name is Bask, and I helped to start the company here. We started Power when my Dad was diagnosed with multiple myeloma, and I needed a better way to understand how he could access the most promising immunotherapy for his illness.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?

      198 Clinical Trials near Long Beach, CA

      Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.

      Learn More About Power
      Image of trial facility.

      Serplulimab + Chemotherapy for Small Cell Lung Cancer

      Long Beach, California
      This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.
      No Placebo Group
      Prior Safety Data
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Mixed SCLC, Severe Allergy, Myocardial Infarction, Others
      Must Not Be Taking:Psychotropic Drugs
      200 Participants Needed
      Image of trial facility.

      Serplulimab + Chemoradiotherapy for Small Cell Lung Cancer

      Long Beach, California
      This trial tests if adding a new drug called Serplulimab to standard treatments (chemotherapy and radiotherapy) can help patients with a specific type of lung cancer. Serplulimab aims to boost the immune system to fight cancer more effectively. Serplulimab has shown benefits when combined with chemotherapy in previous trials.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:18 - 99
      Sex:All
      511 Participants Needed
      Image of trial facility.

      Amlitelimab + Topical Corticosteroids for Eczema

      Long Beach, California
      Active on Power
      This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe AD on background TCS who have had inadequate response to prior biologic or oral JAKi therapy. The purpose of this study is to measure the efficacy and safety of treatment with amlitelimab solution for subcutaneous (SC) injection compared with placebo in participants with moderate-to-severe AD aged 12 years and older on background TCS and have had an inadequate response to prior biologic or an oral JAKi therapy. Study details include: At the end of the treatment period, participants will have the option to enter the Long-Term Safety Study LTS17367 (RIVER-AD). The study duration will be up to 56 weeks for participants not entering the long-term safety study (LTS17367 \[RIVER-AD\]) including a 2 to 4-week screening, a 36-week randomized double-blind period, and a 16-week safety follow-up. The study duration will be up to 40 weeks for participants entering the long-term safety study (LTS17367 \[RIVER-AD\]) including a 2 to 4-week screening and a 36-week randomized double-blind period. The total treatment duration will be up to 36 weeks. The total number of visits will be up to 13 visits (or 12 visits for those entering the long-term safety study LTS17367 \[RIVER-AD\] study).
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:12+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Immunosuppression, Malignancies, Transplant, Infections, Others
      Must Be Taking:Biologics, Oral JAKi
      249 Participants Needed
      Image of trial facility.

      SEP-363856 for Depression

      Long Beach, California
      Active on Power
      A Phase 2/3 Trial is designed to evaluate SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18 - 65
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Schizophrenia, Bipolar, PTSD, Others
      900 Participants Needed
      Image of trial facility.

      EYP-1901 vs Aflibercept for Age-Related Macular Degeneration

      Long Beach, California
      This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
      No Placebo Group
      Prior Safety Data
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:50+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Subfoveal Fibrosis, Atrophy, Scarring, Others
      Must Be Taking:Anti-VEGF Injections
      400 Participants Needed
      Image of trial facility.

      Remternetug for Alzheimer's Disease

      Long Beach, California
      The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo. Participation could last up to 255 weeks including screening, a double-blind treatment period, and a double-blind observation period. In addition, eligible participants who receive placebo during the double-blind treatment period may choose to extend their study participation to receive open-label remternetug in an extension period.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:65 - 80
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Dementia, Neurological Disease, Cancer, Others
      Must Not Be Taking:Anti-amyloid Immunotherapy
      1200 Participants Needed
      Image of trial facility.

      TAK-279 for Psoriasis

      Long Beach, California
      The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 217 weeks, including up to 35 days for the screening period, 52 weeks (Part A) up to 156 additional weeks (Part B) study treatment and 4 weeks follow up period. During the study, participants will visit their study clinic multiple times.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Non-plaque Psoriasis, Cancer, Hypertension, Others
      Must Not Be Taking:Biologics, TNF Inhibitors
      1300 Participants Needed
      Image of trial facility.

      Plozasiran for High Triglycerides

      Long Beach, California
      This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo and be evaluated for efficacy and safety.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Acute Pancreatitis, BMI >45, Others
      Must Be Taking:Lipid-lowering Medications
      1328 Participants Needed
      Image of trial facility.

      Plozasiran for High Triglycerides

      Long Beach, California
      This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo, and be evaluated for efficacy and safety. After Month 12, eligible participants will be offered an opportunity to continue in an optional open-label extension under a separate protocol.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Familial Chylomicronemia, BMI >45, Others
      Must Be Taking:Lipid-lowering Medications
      300 Participants Needed
      Image of trial facility.

      Survodutide for Obesity and Fatty Liver Disease

      Long Beach, California
      This study is open to adults who are at least 18 years old and have * presumed or confirmed NASH together with overweight or obesity and * a body mass index (BMI) of 30 kg/m² or more, or * a BMI of 27 kg/m² and at least one weight-related health problem. People with a history of other chronic liver diseases cannot take part in this study. The purpose of this study is to find out whether a medicine called survodutide helps people living with obesity or overweight and a confirmed or presumed liver disease called nonalcoholic steatohepatitis (NASH) to have less liver fat and to lose weight. Participants are put into 2 groups randomly, which means by chance. 1 group gets different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants and doctors do not know who is in which group. Participants inject survodutide or placebo under their skin once a week for about 1 year. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 3 months. During this time, it is planned that participants visit the study site up to 13 times and receive 3 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. At 3 of the visits, the participants' liver is measured using different imaging methods. The results are compared between the groups to see whether the treatment works.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All
      187 Participants Needed
      Image of trial facility.

      BHV-7000 for Epilepsy

      Long Beach, California
      The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18 - 75
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Status Epilepticus, Cluster Seizures, Others
      Must Be Taking:Anti-seizure Medications
      390 Participants Needed
      Image of trial facility.

      Pelacarsen for Cardiovascular Disease

      Long Beach, California
      Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18 - 80
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Uncontrolled Hypertension, Heart Failure, Malignancy, Others
      Must Be Taking:LDL-C Lowering
      400 Participants Needed
      Image of trial facility.

      Nivolumab + Standard Treatment for Stomach and Esophageal Cancer

      Harbor City, California
      This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
      No Placebo Group
      Prior Safety Data
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Autoimmune Disease, Major Surgery, Others
      Must Not Be Taking:Corticosteroids, Immunosuppressives
      224 Participants Needed
      Image of trial facility.

      Blood Test and Immunotherapy for Bladder Cancer

      Harbor City, California
      This phase II/III trial examines whether patients who have undergone surgical removal of bladder, but require an additional treatment called immunotherapy to help prevent their bladder cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of bladder cancer patients who have undergone surgical removal of their bladder.
      No Placebo Group
      Prior Safety Data
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Autoimmune Disease, Hepatitis, Myocarditis, Others
      Must Be Taking:Immunotherapy
      1190 Participants Needed
      Image of trial facility.

      Chemotherapy + Hormone Therapy for Breast Cancer

      Harbor City, California
      This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18 - 60
      Sex:Female

      Key Eligibility Criteria

      Disqualifiers:Metastatic Disease, Cardiac Disease, Others
      Must Be Taking:Endocrine Therapy
      3960 Participants Needed
      Image of trial facility.

      Selinexor Maintenance Therapy for Endometrial Cancer

      Los Angeles, California
      The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 220 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor or placebo.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Uterine Sarcomas, Active Infection, Others
      Must Not Be Taking:Systemic Steroids
      220 Participants Needed
      Image of trial facility.

      Furmonertinib for Non-Small Cell Lung Cancer

      Long Beach, California
      This trial is testing furmonertinib at two different doses to treat a specific type of lung cancer. It targets patients with advanced or metastatic non-squamous NSCLC who have a particular genetic mutation. The medication works by blocking a protein that helps cancer cells grow, potentially slowing down or stopping the cancer.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Prior Systemic Therapy, Others
      Must Not Be Taking:EGFR-targeting Agents
      398 Participants Needed
      Image of trial facility.

      Shionogi Protease Inhibitor for COVID-19

      Long Beach, California
      This trial will test a new medicine called ensitrelvir to help hospitalized COVID-19 patients by stopping the virus from multiplying.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Severe Hepatic Impairment, Renal Failure, Pregnancy, Others
      Must Not Be Taking:Strong CYP3A Inducers
      1500 Participants Needed
      Image of trial facility.

      COVID-19 Vaccine for Children

      Long Beach, California
      This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary doses of SARS-CoV-2 rS with Matrix-M™ adjuvant (NVX-CoV2373) given 21 days apart and NVX CoV2373 or a variant-based vaccine given as a booster dose or at crossover in pediatric participants (3 age cohorts; 6 to \< 12 years, 2 to \< 6 years, and 6 to \< 24 months of age). Each age cohort will be conducted in 2 parts starting with the oldest age cohort (6 to \< 12 years of age).
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 2, 3
      Age:6 - 11
      Sex:All
      3600 Participants Needed
      Image of trial facility.

      Piromelatine for Alzheimer's Disease

      Long Beach, California
      This trial tests piromelatine, a pill taken before bed, in people with mild Alzheimer's who lack a specific genetic variation. The goal is to see if it can improve brain function and slow down dementia progression.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 2, 3
      Age:60 - 85
      Sex:All
      225 Participants Needed
      Image of trial facility.

      Depemokimab for Severe Asthma

      Long Beach, California
      This trial is testing Depemokimab, a medication for people with severe asthma that doesn't respond well to usual treatments. It works by reducing specific cells that cause airway inflammation, aiming to improve breathing and reduce symptoms.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:12+
      Sex:All
      641 Participants Needed
      Image of trial facility.

      Chemotherapy Tailored by ctDNA Status for Colon Cancer

      Harbor City, California
      This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Metastatic Disease, Prior Chemotherapy, Others
      Must Not Be Taking:Antidepressants, Anticonvulsants
      1912 Participants Needed
      Image of trial facility.

      Atezolizumab + Chemotherapy for Neuroendocrine Carcinoma

      Harbor City, California
      This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
      No Placebo Group
      Prior Safety Data
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Autoimmune Disease, Cardiovascular Disease, Others
      Must Not Be Taking:Glucocorticoids, Immunostimulatory Agents
      189 Participants Needed
      Image of trial facility.

      Anti-Coagulant + Anti-Platelet Therapy for Stroke Prevention

      Long Beach, California
      The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:30+
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Intracranial Tumor, Cardiac Embolism, Others
      Must Not Be Taking:Thrombolytics, Antithrombotics, CYP3A4 Inhibitors
      1683 Participants Needed
      Image of trial facility.

      Donanemab for Alzheimer's Disease

      Long Beach, California
      This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:65 - 80
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Mild Cognitive Impairment, Dementia, Cancer, Others
      Must Not Be Taking:Cognitive Enhancers
      2196 Participants Needed
      Image of trial facility.

      Systemic + Local Therapy for Prostate Cancer

      Long Beach, California
      This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic prostate cancer. Oligometastasis will be defined as 1-10 sites of metastatic disease based on the clinical determination of the LSI which incorporates all imaging, clinical, and pathologic data available.
      No Placebo Group
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 2, 3
      Age:18+
      Sex:Male

      Key Eligibility Criteria

      Disqualifiers:Castration-resistant Prostate Cancer, Brain Metastases, Others
      Must Be Taking:SST Agents
      464 Participants Needed
      Image of trial facility.

      Semaglutide for Early Alzheimer's Disease

      Long Beach, California
      This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will last for up to 173 weeks (about 3 years and 4 months). Participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans. At 10 of the clinic visits participants will have blood samples taken. Participants must have a study partner, who is willing to take part in the study. Women cannot take part if pregnant, breastfeeding or plan to become pregnant during the study period. A cerebrospinal fluid (CSF) sub-study will be performed as a part of the study. The sub-study will be performed on a selection of sites based on their experience with CSF sampling and willingness to participate in this sub-study. The endpoints related to this sub-study are exploratory only.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:55 - 85
      Sex:All
      1840 Participants Needed
      Image of trial facility.

      Depemokimab for Asthma

      Long Beach, California
      This trial is testing a new medication called Depemokimab for people with severe asthma who have high levels of certain white blood cells. The goal is to see if switching to Depemokimab works as well as their current treatments. The medication aims to reduce these white blood cells to help control asthma symptoms.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:12+
      Sex:All
      1719 Participants Needed
      Image of trial facility.

      Rimegepant for Pediatric Migraine

      Long Beach, California
      The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
      Pivotal Trial
      Trial Details
      Trial Status:Recruiting
      Trial Phase:Phase 3
      Age:6 - 17
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:Cluster Headache, Uncontrolled Psychiatric, Substance Abuse, Others
      Must Be Taking:Prophylactic Migraine
      2100 Participants Needed
      Image of trial facility.

      Etavopivat for Sickle Cell Disease

      Long Beach, California
      This trial is testing a drug called etavopivat to see if it can help people with sickle cell disease. The drug aims to improve blood health and reduce pain by making red blood cells work better. The study includes patients aged 12 to 65.
      Pivotal Trial
      Trial Details
      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:12 - 65
      Sex:All

      Key Eligibility Criteria

      Disqualifiers:HIV, Hepatitis B/C, Renal Dysfunction, Others
      Must Be Taking:Hydroxyurea, Crizanlizumab, L-glutamine
      450 Participants Needed
      Page 1 of 7+
      Why We Started Power

      My name is Bask, and I helped to start the company here. We started Power when my Dad was diagnosed with multiple myeloma, and I needed a better way to understand how he could access the most promising immunotherapy for his illness.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?

      Frequently Asked Questions

      How much do clinical trials in Long Beach, CA pay?

      Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.

      How do clinical trials in Long Beach, CA work?

      After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Long Beach, CA 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Long Beach, CA is 12 months.

      How do I participate in a study as a "healthy volunteer"?

      Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Long Beach, CA several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.

      What does the "phase" of a clinical trial mean?

      The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.

      Do I need to be insured to participate in a medical study in Long Beach, CA ?

      Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

      What are the newest clinical trials in Long Beach, CA ?

      Most recently, we added Izalontamab Brengitecan for Breast Cancer, Maridebart Cafraglutide for Obesity and Suzetrigine for Diabetic Neuropathy to the Power online platform.